Recommended Age Range for Coronary Artery Calcium Scanning
Coronary artery calcium (CAC) scanning is generally recommended for asymptomatic adults aged 40-75 years with intermediate cardiovascular risk, with selective use in younger individuals who have significant risk factors. 1
General Age Guidelines
- Standard recommendation: 40-75 years 1, 2
- Lower age limit: Generally not recommended for men <40 years and women <50 years due to low prevalence of detectable calcium 1
- Upper age limit: Limited utility after age 75, with caution advised for routine use in adults >70 years 1
Risk-Based Age Recommendations
CAC scanning is most appropriate for:
Intermediate risk individuals (40-75 years):
Borderline risk individuals (40-75 years):
- 10-year ASCVD risk of 5-7.5% 1
- CAC can help with shared decision-making about preventive therapies
Low risk individuals with specific risk enhancers:
- Strong family history of premature CAD 1
- Genetic dyslipidemias
- Smoking history
- Diabetes
Sex-Specific Considerations
Women: Generally develop CAC approximately 10 years later than men 1
Men: Develop CAC earlier than women
Risk Factor-Based Age Adjustments
Certain risk factors warrant earlier CAC testing 3:
- Diabetes: Accelerates CAC development by approximately 6.4 years
- Smoking, hypertension, dyslipidemia, family history: Each accelerates CAC development by 3.3-4.3 years
Repeat Testing Intervals
If CAC testing is performed, follow-up intervals should be 1, 2, 4:
- CAC = 0: Repeat in 5-7 years
- CAC = 1-99: Repeat in 3-5 years
- CAC = 100-400: Repeat in 3 years
- CAC > 400: May not require repeat scanning as these patients often require aggressive treatment
Important Caveats
- Testing should only be performed if results will influence treatment decisions 4
- Radiation exposure: While low (typically 1.5 mSv), this is still a consideration 1
- Cost-effectiveness: Currently limited data on cost-effectiveness in Australia and New Zealand 4
- Not recommended for patients with established ASCVD 1
- USPSTF position: Differs from other guidelines, stating evidence is insufficient for CAC addition to traditional CV risk assessment 1
Clinical Decision Algorithm
- Determine baseline 10-year ASCVD risk using Pooled Cohort Equations
- Consider CAC if:
- Age 40-75 AND
- Intermediate risk (7.5-19.9%) OR
- Borderline risk (5-7.5%) with risk enhancers OR
- Low risk (<5%) with strong family history of premature CAD
- Consider earlier testing (age 30-39) only for:
- Type 1 diabetes >20 years duration
- Type 2 diabetes >10 years duration
- Multiple major ASCVD risk factors
- Strong family history of premature ASCVD
CAC scoring provides valuable risk stratification beyond traditional risk calculators and can guide decisions about preventive therapies, particularly statins, in appropriate age groups.